Dr. Vaishnavi Joshi

Special interest: Breast Cancer, Lymphoma ,Myeloma
Experience: 6 years
Specialization: Gynaecological Malignancies
Qualification:MBBS : 2001-2007- Govt Medical College, Mysore MD in General Medicine : 2008-2011- Govt Medical College , Madurai,Madurai DNB Medical Oncology : 2013 -2016 Apollo Hospital Bannergatta road

Dr. Vaishnavi Joshi is a well trained Medical Oncologist in Bangalore with five years of experience in treating all kinds of solid tumors as well as hematological malignancies.
She completed her medical graduation from Government Medical college, Mysore and Post-graduation in Internal Medicine from Madurai Medical College securing “API GOLD MEDAL IN INTERNAL MEDICINE”.
She completed her DNB in Medical oncology from Apollo hospitals, Bannerghatta road, Bangalore. She is accredited with ESMO(European society of Medical Oncology) certification in the year 2018.
Currently working as a Consultant Medical oncologist in Apollo Hospital Sheshadripuram and Jayanagar since 2016. Dr. Vaishnavi has to date presented and published several papers in National and international forums including a chapter on “Gynecological Malignancies” in API textbook of Medicine. She is actively involved in Autologous stem cell transplantation programs for myeloma and lymphoma in Apollo Hospital. Her special areas of interest are curable cancers, “Cancer in Women” including Breast cancer and Gynaec cancers and Multiple myelomas.
She is passionate and enthusiastic about cancer prevention in women and society as a whole and has conducted numerous talks and public interactions for the past five years.
She believes in evidence based cancer care guided by scientific principles, ethics and most importantly empathy and compassion.

• Gynecological Malignancies “ ,10^thedition, API textbook of Medicine 2014-15- Co Author with Dr PP Bapsy.
• P Anoop FRCPCH FRCPath , C N Patil MD DM, Vaishnavi S Joshi MD DNB , Poonam Maurya DNB , Pradeep Hosamani MS, Departments Of Heamato-Oncology And ENT, Apollo Hospitals Bangalore.
• Sensorineural deafness : An Uncommon irreversible adverse effect of  bortezomib- A case report , Indian Journal Of Cancer-(In Press)